Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.33	26.29	30.78	109.28	52.25
Short-Term Investments	86.29	99.72	116.14	46.04	71.02
Cash & Short-Term Investments	122.62	126	146.91	155.32	123.27
Cash Growth	-2.68%	-14.23%	-5.41%	26.00%	35.71%
Accounts Receivable	2.41	1.78	1.35	0.9	1.31
Other Receivables	0.3	0.6	-	-	-
Receivables	2.71	2.38	1.35	0.9	1.31
Prepaid Expenses	1.98	3.65	2.87	4.45	3.12
Total Current Assets	127.32	132.03	151.14	160.66	127.7
Property, Plant & Equipment	4.36	6.09	6.81	8.08	9.33
Long-Term Investments	-	6.28	37.36	35.69	-
Other Long-Term Assets	0.03	-	0.1	0.06	0.04
Total Assets	131.71	144.4	195.42	204.49	137.08
Accounts Payable	2.32	3.22	3.52	3.17	2.99
Accrued Expenses	5.25	7.05	12.51	7.66	6.16
Current Portion of Leases	0.48	0.43	0.37	0.38	0.39
Current Unearned Revenue	7.57	11.79	16.46	-	-
Total Current Liabilities	15.62	22.49	32.86	11.22	9.54
Long-Term Debt	4.83	6.95	10.37	16.3	19.55
Long-Term Leases	0.81	1.34	1.82	2.23	2.59
Long-Term Unearned Revenue	2.86	-	6	-	-
Other Long-Term Liabilities	10.23	7.6	7.53	5.3	3.43
Total Liabilities	34.34	38.38	58.57	35.05	35.11
Common Stock	1,410	1,350	1,319	1,287	985.94
Additional Paid-In Capital	82.05	81.27	72.41	65.49	60.75
Retained Earnings	-1,347	-1,277	-1,204	-1,134	-1,046
Comprehensive Income & Other	-48.14	-48.42	-50.49	-48.34	-48.17
Total Common Equity	97.37	106.02	136.85	169.44	-47.44
Shareholders' Equity	97.37	106.02	136.85	169.44	101.97
Total Liabilities & Equity	131.71	144.4	195.42	204.49	137.08
Total Debt	6.12	8.72	12.55	18.91	22.54
Net Cash (Debt)	116.51	123.57	171.72	172.1	100.73
Net Cash Growth	-5.71%	-28.04%	-0.22%	70.85%	47.09%
Net Cash Per Share	0.63	0.74	1.14	1.62	1.33
Filing Date Shares Outstanding	191.48	179.49	162.57	148.64	95.58
Total Common Shares Outstanding	189.96	169.87	157.46	144.99	89.68
Working Capital	111.7	109.54	118.28	149.44	118.16
Book Value Per Share	0.51	0.62	0.87	1.17	-0.53
Tangible Book Value	97.37	106.02	136.85	169.44	-47.44
Tangible Book Value Per Share	0.51	0.62	0.87	1.17	-0.53
Machinery	7.72	7.98	7.28	6.79	5.99
Leasehold Improvements	8.59	8.59	8.59	8.56	8.56

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q